Benralizumab strongly reduces blood basophils in severe eosinophilic asthma. Lommatzsch M, Marchewski H, Schwefel G, Stoll P, et al. Clin Exp Allergy 2020 Aug 6. doi: 10.1111/cea.13720.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lommatzsch M, Marchewski H, Schwefel G, Stoll P, et al. Benralizumab strongly reduces blood basophils in severe eosinophilic asthma. Clin Exp Allergy 2020 Aug 6. doi: 10.1111/cea.13720.
PMID: 32762056